ÂÜÀòÂÒÂ×

Mark Flower has extensive experience in the life sciences industry with a focus on cell and gene therapy. Mark currently serves as the Vice President of Business Development for Cryoport, a global leader in temperature-controlled supply chain solutions for the life sciences industry. In this role, they are responsible for the IntegriCellâ„¢ platform, which aims to establish a standardized cryopreservation and distribution solution for the global cell therapy market.

Prior to their current position, Mark held various leadership roles in the industry. Mark served as the Vice President of Business Development and Strategic Partnerships for Be The Match BioTherapies, where they managed the cell therapy supply chain delivery for autologous or allogeneic therapies. Mark also served as the Executive Director of Sales and Marketing for Hitachi Chemical Advanced Therapeutics Solutions, LLC, a global cell therapy CDMO service platform.

Mark has been actively involved in the cell and gene therapy community. Mark served on the North America Regional Executive Committee as Treasurer for the International Society for Cell & Gene Therapy (ISCT), a global society focused on translating cell and gene therapy into safe and effective therapies. Additionally, they were a Senior Product Manager for Breg Inc, Orthofix Sports Medicine, and held various marketing roles at Terumo BCT and CaridianBCT.

Overall, Mark Flower's work experience demonstrates their expertise in the cell and gene therapy industry and their commitment to advancing treatments and improving patients' lives worldwide.

Mark Flower earned a Bachelor of Science degree in Biological Science from UC San Diego, where they studied from 1987 to 1992.